Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication January 12, 2011
- Accepted for publication April 20, 2011
- Published online August 1, 2011.
Article Versions
- previous version (July 15, 2011 - 06:29).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2011 by Society of Nuclear Medicine
Author Information
- Rebecca A. Dumont1,
- Friederike Deininger1,
- Roland Haubner2,
- Helmut R. Maecke1,
- Wolfgang A. Weber1 and
- Melpomeni Fani1
- 1Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany; and
- 2Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria
- For correspondence or reprints contact: Melpomeni Fani, Department of Nuclear Medicine, University Hospital Freiburg, Hugstetterstrasse 55, D-79106 Freiburg, Germany. E-mail: melpomeni.fani{at}uniklinik-freiburg.de
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- 61Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging
- Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins {alpha}5{beta}1 and {alpha}v{beta}3
- Does Imaging {alpha}v{beta}3 Integrin Expression with PET Detect Changes in Angiogenesis During Bevacizumab Therapy?
- Can 111In-RGD2 Monitor Response to Therapy in Head and Neck Tumor Xenografts?
- Noninvasive positron emission tomography and fluorescence imaging of CD133+ tumor stem cells
- Inflammatory neovascularization during graft-versus-host disease is regulated by {alpha}v integrin and miR-100